Reports
Reports
Sale
The key features of the market report include patent analyses, funding and investment analysis, strategic initiatives by the leading key players. The major companies in the market are as follows:
Danaher Corporation
Founded in 1969 and headquartered in Washington, this company produces a variety of flow cytometry products like clinical flow cytometer, Navios EX flow cytometer, CytoFLEX nano Flow Cytometer.
Becton, Dickinson, and Company
Founded in 1897, and headquartered in New Jersey, United States, Becton, Dickinson and Company (BD) has launched a range of flow cytometry products, including BD FACSDuet, BD FACSDuet Premium, BD Horizon RealYellow and RealBlue Reagents.
SYSMEX CORPORATION
Headquartered in Japan, this company manufactures a variety of products including XF-1600, CyFlow Cube 6, CyFlow Cube 8, CyFlow Space, and PS-10.
Agilent Technologies, Inc.
California, United based Agilent Technologies was established in 1999. The company produces Agilent NovoCyte Penteon, NovoCyte Flow Cytometer. Deploying latest technologies into their equipment, the company is projected to bring advanced cytometers in the market.
Other companies in the market include Beckman Coulter, Inc., Apogee Flow Systems Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Stratedigm, Inc., DiaSorin SpA, Miltenyi Biotec, Sony Biotechnology, Inc., Nanocellect Biomedical, Inc., and Merck KGaA.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Flow Cytometry Market Regional Analysis
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Flow Cytometry Market Overview
3.1 Global Flow Cytometry Market Historical Value (2017-2023)
3.2 Global Flow Cytometry Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Flow Cytometry Market Landscape*
5.1 Global Flow Cytometry: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Flow Cytometry: Product Landscape
5.2.1 Analysis by Product & Services
5.2.2 Analysis by Application
5.2.3 Analysis by Technology
6 Global Flow Cytometry Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Environmental
6.3.3 Social
6.3.4 Technological
6.3.5 Ethical
6.3.6 Legal
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Flow Cytometry Market Segmentation (2017-2032)
7.1 Global Flow Cytometry Market (2017-2032) by Product & Services
7.1.1 Market Overview
7.1.2 Instruments
7.1.2.1 Cell Sorters
7.1.2.2 Cell Analyzers
7.1.3 Reagents and Consumables
7.1.4 Solutions & Software
7.1.5 Services
7.2 Global Flow Cytometry Market (2017-2032) by Technology
7.2.1 Market Overview
7.2.2 Bead-based
7.2.3 Cell-based
7.3 Global Flow Cytometry Market (2017-2032) by Application
7.3.1 Market Overview
7.3.2 Research
7.3.2.1 Cell Sorting
7.3.2.2 Immunology
7.3.2.3 Apotosis
7.3.2.4 Pharmaceutical & Biotechnology
7.3.2.5 Others
7.3.3 Clinical
7.3.3.1 Hematology
7.3.3.2 Organ Transplantation
7.3.3.3 Autoimmune Diseases
7.3.3.4 Cancer Diagnosis
7.3.4 Industrial
7.3.5 Others
7.4 Global Flow Cytometry Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Hospitals
7.4.3 Biotechnology and Pharmaceutical Companies
7.4.4 CROs
7.4.5 Clinical and Diagnostic Labs
7.4.6 Research and Academic Institutes
7.5 Global Flow Cytometry Market (2017-2032) by Region
7.5.1 Market Overview
7.5.2 North America
7.5.3 Europe
7.5.4 Asia Pacific
7.5.5 Latin America
7.5.6 Middle East and Africa
8 North America Flow Cytometry Market (2017-2032)
8.1 North America Flow Cytometry Market (2017-2032) by Product & Services
8.1.1 Market Overview
8.1.2 Instruments
8.1.2.1 Cell Sorters
8.1.2.2 Cell Analyzers
8.1.3 Reagents and Consumables
8.1.4 Solutions & Software
8.1.5 Services
8.2 North America Flow Cytometry Market (2017-2032) by Technology
8.2.1 Market Overview
8.2.2 Bead-based
8.2.3 Cell-based
8.3 North America Flow Cytometry Market (2017-2032) by Application
8.3.1 Market Overview
8.3.2 Research
8.3.2.1 Cell Sorting
8.3.2.2 Immunology
8.3.2.3 Apotosis
8.3.2.4 Pharmaceutical & Biotechnology
8.3.2.5 Others
8.3.3 Clinical
8.3.3.1 Hematology
8.3.3.2 Organ Transplantation
8.3.3.3 Autoimmune Diseases
8.3.3.4 Cancer Diagnosis
8.3.4 Industrial
8.3.5 Others
8.4 North America Flow Cytometry Market (2017-2032) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Flow Cytometry Market (2017-2032)
9.1 Europe Flow Cytometry Market (2017-2032) by Product & Services
9.1.1 Market Overview
9.1.2 Instruments
9.1.2.1 Cell Sorters
9.1.2.2 Cell Analyzers
9.1.3 Reagents and Consumables
9.1.4 Solutions & Software
9.1.5 Services
9.2 Europe Flow Cytometry Market (2017-2032) by Technology
9.2.1 Market Overview
9.2.2 Bead-based
9.2.3 Cell-based
9.3 Europe Flow Cytometry Market (2017-2032) by Application
9.3.1 Market Overview
9.3.2 Research
9.3.2.1 Cell Sorting
9.3.2.2 Immunology
9.3.2.3 Apotosis
9.3.2.4 Pharmaceutical & Biotechnology
9.3.2.5 Others
9.3.3 Clinical
9.3.3.1 Hematology
9.3.3.2 Organ Transplantation
9.3.3.3 Autoimmune Diseases
9.3.3.4 Cancer Diagnosis
9.3.4 Industrial
9.3.5 Others
9.4 Europe Flow Cytometry Market (2017-2032) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Flow Cytometry Market (2017-2032)
10.1 Asia Pacific Flow Cytometry Market (2017-2032) by Product & Services
10.1.1 Market Overview
10.1.2 Instruments
10.1.2.1 Cell Sorters
10.1.2.2 Cell Analyzers
10.1.3 Reagents and Consumables
10.1.4 Solutions & Software
10.1.5 Services
10.2 Asia Pacific Flow Cytometry Market (2017-2032) by Technology
10.2.1 Market Overview
10.2.2 Bead-based
10.2.3 Cell-based
10.3 Asia Pacific Flow Cytometry Market (2017-2032) by Application
10.3.1 Market Overview
10.3.2 Research
10.3.2.1 Cell Sorting
10.3.2.2 Immunology
10.3.2.3 Apotosis
10.3.2.4 Pharmaceutical & Biotechnology
10.3.2.5 Others
10.3.3 Clinical
10.3.3.1 Hematology
10.3.3.2 Organ Transplantation
10.3.3.3 Autoimmune Diseases
10.3.3.4 Cancer Diagnosis
10.3.4 Industrial
10.3.5 Others
10.4 Asia Pacific Flow Cytometry Market (2017-2032) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Flow Cytometry Market (2017-2032)
11.1 Latin America Flow Cytometry Market (2017-2032) by Product & Services
11.1.1 Market Overview
11.1.2 Instruments
11.1.2.1 Cell Sorters
11.1.2.2 Cell Analyzers
11.1.3 Reagents and Consumables
11.1.4 Solutions & Software
11.1.5 Services
11.2 Latin America Flow Cytometry Market (2017-2032) by Technology
11.2.1 Market Overview
11.2.2 Bead-based
11.2.3 Cell-based
11.3 Latin America Flow Cytometry Market (2017-2032) by Application
11.3.1 Market Overview
11.3.2 Research
11.3.2.1 Cell Sorting
11.3.2.2 Immunology
11.3.2.3 Apotosis
11.3.2.4 Pharmaceutical & Biotechnology
11.3.2.5 Others
11.3.3 Clinical
11.3.3.1 Hematology
11.3.3.2 Organ Transplantation
11.3.3.3 Autoimmune Diseases
11.3.3.4 Cancer Diagnosis
11.3.4 Industrial
11.3.5 Others
11.4 Latin America Flow Cytometry Market (2017-2032) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Flow Cytometry Market (2017-2032)
12.1 Middle East and Africa Flow Cytometry Market (2017-2032) by Product & Services
12.1.1 Market Overview
12.1.2 Instruments
12.1.2.1 Cell Sorters
12.1.2.2 Cell Analyzers
12.1.3 Reagents and Consumables
12.1.4 Solutions & Software
12.1.5 Services
12.2 Middle East and Africa Flow Cytometry Market (2017-2032) by Technology
12.2.1 Market Overview
12.2.2 Bead-based
12.2.3 Cell-based
12.3 Middle East and Africa Flow Cytometry Market (2017-2032) by Application
12.3.1 Market Overview
12.3.2 Research
12.3.2.1 Cell Sorting
12.3.2.2 Immunology
12.3.2.3 Apotosis
12.3.2.4 Pharmaceutical & Biotechnology
12.3.2.5 Others
12.3.3 Clinical
12.3.3.1 Hematology
12.3.3.2 Organ Transplantation
12.3.3.3 Autoimmune Diseases
12.3.3.4 Cancer Diagnosis
12.3.4 Industrial
12.3.5 Others
12.4 Middle East and Africa Flow Cytometry Market (2017-2032) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership and Collaborations
16.3 Analysis by Joint Ventures
16.4 Analysis by Leading Players
16.5 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia-Pacific
17.1.5 Market Share Analysis: Others
17.2 Danaher Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Becton, Dickinson, and Company
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Beckman Coulter, Inc .
17.4.1 Product Portfolio
17.4.2 Demographic Reach and Achievements
17.4.3 Mergers and Acquisitions
17.4.4 Certifications
17.5 SYSMEX CORPORATION
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Agilent Technologies , Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Apogee Flow Systems Ltd .
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Bio-Rad Laboratories, Inc .
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Thermo Fisher Scientific, Inc .
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Stratedigm, Inc .
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 DiaSorin S.p .A.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Miltenyi Biotec
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Sony Biotechnology, Inc .
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Merck KGaA
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Nanocellect Biomedical, Inc .
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Flow Cytometry Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.